| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.85B | -1.5% |
| R&D Expense | $146.0M | +2.1% |
| SG&A Expense | $3.29B | +6.1% |
| Operating Income | $8.02B | +49.5% |
| Interest Expense | $480.0M | +73.3% |
| Pre-tax Income | $7.99B | +44.1% |
| Income Tax | $1.81B | +26.5% |
| Net Income | $6.20B | +49.5% |
| EPS (Basic) | $12.70 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.66B | -14.2% |
| Accounts Receivable | $4.72B | +3.5% |
| Inventory | $2.12B | +6.9% |
| Current Assets | $12.62B | -3.3% |
| Total Assets | $80.81B | +1.4% |
| Current Liabilities | $15.72B | -4.6% |
| Long-term Debt | $14.66B | +6.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.30B | +5.0% |
| Capital Expenditures | $3.79B | +19.4% |
| Investing Cash Flow | -$4.67B | -51.2% |
| Financing Cash Flow | -$5.40B | -74.8% |
| Free Cash Flow | $5.52B | -3.0% |
| +53.0% |
| EPS (Diluted) | $12.59 | +53.0% |
| Total Liabilities |
| $39.72B |
| +3.8% |
| Stockholders' Equity | $39.72B | -0.8% |